Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SOR-007 by Nanology for Small-Cell Lung Cancer: Likelihood of Approval
SOR-007 is under clinical development by Nanology and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase...
Data Insights
SOR-007 by Nanology for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
SOR-007 is under clinical development by Nanology and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According to...